Debate of the Decade: RCTs in the Era of Precision Oncology
How do you design clinical trials in the era of precision oncology? Are prospective randomized controlled trials necessary anymore? Drs. Ray Kurzrock, Vivek Subbiah, and Christopher Booth join Dr. Chadi Nabhan to answer these important questions.
Survival Outcomes of Neoadjuvant mFOLFIRINOX for Resectable PDAC
Officials Provide Update on Phase 2 Trial of THIO Plus Cemiplimab in NSCLC
Examining the Lifetime Risk of Gastric Cancer in Patients With CDH1 Gene Variants